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taBLe of ContentS
Recent results from clinical trials of potential new HIV prevention interventions 
underscore what we have known for decades: Wider delivery of effective behavior 
change strategies is central to reversing the global HIV epidemic. The availability of 
new biomedical HIV prevention modalities, such as vaccines and microbicides, is still 
many years away. Even when these tools finally emerge, human behavior will remain 
critical, as new prevention strategies are unlikely to be 100 percent effective in preventing 
transmission. With 2.5 million new HIV infections in 2007, there is an obvious and 
urgent need to pursue the effective strategies we have to promote safer behaviors. 
Human behavior is complex; widespread behavior changes are challenging to achieve; 
and there are important gaps in our knowledge about the effectiveness of HIV prevention. 
Yet the research to date clearly documents the impact of numerous behavioral 
interventions in reducing HIV infection. We also know that in all cases in which national 
HIV epidemics have reversed, broad-based behavior changes were central to success. 
To be more effective in the 21st century, the HIV prevention effort must confront several 
challenges of perception: misplaced pessimism about the effectiveness of behavioral HIV 
prevention strategies; unfortunate confusion between the difficulty in changing human 
behavior and the inability to do so; and misperception that because it is inherently 
difficult to measure prevention success—a “nonevent”—prevention efforts have no 
impact. 
This report from the Global HIV Prevention Working Group (PWG) focuses specifically 
on behavioral HIV prevention. The report surveys what we know about the effectiveness 
of behavior change strategies, what we still need to learn, and what we need to do to 
advance such efforts in coming years. Based on a comprehensive review of hundreds 
of studies of behavior change for HIV prevention, we find that the evidence base for 
behavioral HIV prevention is robust, with multiple studies documenting the effectiveness 
of interventions in numerous settings, among diverse populations, and throughout 
the course of the epidemic. Our review also indicates that the evidence base is not yet 
complete, and that important gaps and limitations remain in our knowledge about what 
works. Maximizing the effectiveness of prevention efforts requires that these limitations 
be acknowledged and addressed. 
exeCUtive SUmmary
( 4 )
What We KnoW 
A comprehensive review of the evidence documents 
both the efficacy (the impact seen in a clinical trial 
setting) and the effectiveness (the impact seen in real-
world settings) of behavioral HIV prevention efforts. 
Encompassing both randomized controlled trials and 
observational analyses, our review identified common 
elements of success: 
•  Randomized ContRolled tRials: 
Hundreds of randomized controlled trials1 have 
demonstrated that individual, small group, and 
community-level interventions can generate 
safer behaviors. For example, a recent review 
of 18 meta-analyses of sexual risk reduction 
interventions found significant increases in 
condom use and reductions in unprotected 
sex (noar 2008). on the basis of peer-reviewed 
publications through 2004, the u.S. Centers 
for Disease Control identified 42 prevention 
interventions that were demonstrated by well-
designed studies to be efficacious (lyles 2007; 
CDC 2001). Studies in low- and middle-income 
countries among young people (WHo 2006), sex 
workers (Foss 2007), and other populations have 
demonstrated that prevention programs have the 
ability to change sexual and drug-use behaviors 
in resource-limited settings to prevent HIV 
transmission. 
•  obseRvational ReseaRCh: Successes have 
been well-studied and documented through 
observational research in uganda, thailand, 
australia, brazil, and numerous other places. 
the early achievements of uganda and thailand 
in implementing effective prevention programs 
have been well-documented (unaIDS 2001), 
as has australia’s striking success in sharply 
lowering HIV incidence as a result of significant 
behavior changes among men who have sex 
with men (national Centre in HIV epidemiology 
and Clinical Research 2007; bowtell 2005). as 
a result of strong national support for multiple 
complementary HIV prevention strategies, 
brazil’s epidemic in the early part of this decade 
was half the size of projections based on infection 
trends in the late 1980s and early 1990s (Ministry 
of Health 2003). analysis across multiple 
studies indicates that national implementation 
of evidence-based combination HIV prevention 
efforts in the 1990s was associated with a 50 to 90 
percent decline in HIV incidence and prevalence 
in key populations (auerbach 2006).
•  Common elements of suCCess: according 
to the available evidence from these and other 
studies, effective strategies pursue a combination 
of behavior change approaches that are delivered 
with sufficient coverage, intensity, and duration, 
and that are tailored to address the main drivers 
of HIV transmission in national epidemics. 
effective HIV prevention addresses the specific 
needs and circumstances of the target population 
and aims to affect multiple determinants of 
human behavior, including individual knowledge 
and motivations, interpersonal relationships, and 
societal norms. Community engagement and 
strong political support have been key ingredients 
of successful national efforts to change behavior 
to prevent HIV infection.  
What We need to Learn
Although much evidence exists to demonstrate that 
it is possible to change human behavior to reduce the 
risk of HIV transmission, there are important gaps 
and limitations in what is known. There is also an 
inherent challenge in measuring the impact of any 
health effort that includes HIV prevention: measuring 
and determining causality for an event that did not 
occur (for example, an HIV infection averted) is 
intrinsically more complicated than evaluating an 
event or phenomenon that did happen. Some of the 
key limitations in what we know and areas in need of 
additional research follow: 
•  moving fRom effiCaCy to effeCtiveness: 
For both biomedical and behavioral interventions, 
it is often difficult to translate the impact seen in 
clinical trials (efficacy) into comparable results 
in the real world (effectiveness). Most clinical 
trials of behavioral HIV prevention programs 
have occurred in high-income countries, using 
intensive, professional program models that 
may not apply in more resource-limited settings 
or in different cultures. Few trials of behavior 
interventions have used such biological end 
points as incidence of HIV or sexually transmitted 
infections (StI), which potentially reduces 
confidence that behavior changes documented in 
clinical trials will have a public health impact in 
the real world.
•  geneRalizability: even where there is 
evidence of effectiveness in real-world settings, 
key questions remain about the transferability 
of these successes to other communities, 
subgroups, and types of epidemics (for example, 
high-prevalence, concentrated, etc.). 
Behavior Change and hiv Prevention
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1  The National Institutes of Health defines a randomized controlled trial as “a 
prospective experiment in which investigators randomly assign an eligible 
sample of patients to one or more treatment groups and a control group and 
follow patients’ outcomes” (National Library of Medicine 2007).
•  sustaining behavioR Change oveR the 
Long term: Few clinical trials for behavior 
interventions have followed participants for 
more than 12 months. Yet emerging evidence 
suggests that favorable behavior changes seen 
in individuals during the first year following 
exposure to a prevention intervention can fade 
over time (Coates In press). at the population 
level, positive behavior changes often fail to 
endure because these changes require a level of 
diligence—for example, consistent condom use—
that is often difficult to maintain over the course 
of people’s everyday lives and within their social 
contexts. In uganda, thailand, and many high-
income countries, early prevention successes 
have been followed years later by marked 
increases in risk behavior, which underscores 
the difficulty of sustaining prevention gains. It can 
be particularly difficult to preserve prevention 
achievements in the face of changes in the 
underlying social or physical environment that 
make HIV seem less threatening.
•  assumptions about individual agenCy: 
existing models of behavior interventions are 
often based on various cognitive behavioral 
theories that assume that individuals will take 
steps to avoid risks if they are fully informed 
and sufficiently motivated—that is, that they can 
exercise personal “agency” in the context of HIV-
associated risk. Yet individual behavior is often  
heavily influenced by broader socioeconomic, 
cultural, and environmental factors. More 
validated program models are needed that affect 
social norms and institutions, although to date 
social and ethnographic research studies have 
not been sufficiently used to inform behavioral 
interventions. 
•  one-dimensional evaluations: Few 
prevention trials have studied combinations 
of interventions, opting instead to evaluate 
the behavioral and epidemiological impact of 
discrete components of comprehensive HIV 
prevention strategies (for example, individual 
behavioral interventions, voluntary HIV testing 
and counseling, or condom promotion). this 
approach runs counter to actual prevention 
practice and the way people live their lives and 
make decisions, rendering it difficult to gauge 
the likelihood of success in the field when these 
individual approaches are combined with other 
prevention components. often, national programs 
and donor initiatives have opted to support certain 
elements of a comprehensive prevention strategy 
while ignoring others, diminishing their impact 
on behaviors and HIV incidence (see Corno and de 
Walque 2007; Fiellin 2007).
What We need to do—
reCommendationS
Significantly increasing the long-term effectiveness of 
HIV behavior change will require countries, donors, 
researchers, civil society, and other stakeholders to 
work together to expand the evidence base for HIV 
prevention—to address the limitations and gaps that 
still exist, while also putting available evidence to use 
in the most strategic manner possible. On the basis of 
the best available evidence, the Prevention Working 
Group recommends the following: 
•  foR national authoRities and 
governmentS: national political and public 
health leaders should develop and implement 
national aIDS strategies and operational plans 
that are tailored to the particular dynamics 
of national epidemics, integrate prevention 
and treatment services, and bring prevention 
interventions to a scale sufficient to have 
measurable impact. Countries scaling up medical 
male circumcision—and other new interventions 
that prove effective—should combine these efforts 
with complementary behavior interventions to 
avoid the increases in risk behavior that can occur 
when new strategies or tools are introduced. 
•  foR inteRnational donoRs: Donors should 
commit to rapidly fund national HIV prevention 
programs that are tailored to national epidemics. 
additionally, they should make available by 2010 
at least u.S. $11.9 billion annually to support 
scale-up of evidence-based HIV prevention 
programs as part of a comprehensive response 
to HIV. Donors should ensure robust financing for 
community-driven responses that build local civil-
society capacity and leadership (unaIDS 2007).
•  foR teChniCal agenCies: Multilateral 
and other technical agencies should develop a 
mechanism to assess the soundness of national 
HIV prevention strategies, identifying instances 
where national plans conflict with available 
evidence about the dynamics of HIV incidence, 
or where selected prevention strategies are 
not based on evidence of what is effective with 
particular populations. technical agencies 
should increase their assistance to countries in 
integrating social-research findings into national 
strategic planning. Improving national HIV-
information systems and their use in national 
planning should remain a priority for technical 
support.
•  foR hiv seRviCe pRovideRs: Sponsors of 
HIV prevention programs should forge strong 
working partnerships with affected communities 
to ensure that programs are optimally tailored to 
Behavior Change and hiv Prevention 
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local circumstances and needs and are ethically 
conducted. Providers of HIV prevention services 
should integrate their efforts with other service 
systems, such as those for tuberculosis and 
sexual and reproductive health. Drug treatment 
programs should be adequately resourced to 
provide for the routine provision of HIV prevention 
services to their clients.
•  foR Civil soCiety: aIDS activists and other 
civil-society groups should strongly advocate for 
the simultaneous scaling up of HIV prevention and 
treatment. Civil-society groups should participate 
in the development of national HIV prevention 
targets, monitor national progress toward their 
achievement, and push for strategies that deliver 
evidence-based interventions to those populations 
most at risk of HIV infection.
•  foR hiv pRevention ReseaRCheRs: Greater 
priority should be placed on social research to 
inform the design and delivery of prevention 
interventions, the adaptation of model programs 
to particular populations or settings, and the 
targeting and delivery of prevention services. 
Researchers and their funding agencies should 
increase their focus on basic research about 
the social drivers of HIV transmission, and the 
development and evaluation of community-level 
interventions, structural interventions, and 
prevention approaches for populations most 
at risk of HIV exposure. additional research 
is required to assess the effectiveness of HIV 
prevention programs in the field and to develop 
and evaluate prevention models that prevent 
risk compensation in response to treatment or 
the introduction and uptake of new prevention 
technologies. Prevention trials should increase 
their use of biological endpoints, where possible 
and appropriate, and the length of time over 
which study participants are followed.
ConCLUSion
Although much work remains to expand the 
evidence base for HIV prevention, this Prevention 
Working Group review argues for the urgency of 
scaling up programs to change behavior to prevent 
HIV infection. The evidence on behavior change 
HIV prevention cannot be overstated, but it also 
must not be overlooked. The central problem in 
HIV prevention is not lack of evidence but failure to 
bring to scale programming that addresses the major 
drivers of HIV infection in specific national settings.  
In the 21st century, pessimism about the real 
challenges ahead, or concern that we do not yet have 
all the answers, should not stop us from preventing 
the next HIV infection. 
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as HIV infection is invariably the result of human behavior,  
change in behavior has long been understood as essential to 
curbing the spread of infection. In all cases where national 
epidemics have been reversed, broad-based behavior  
changes were central to success. 
Yet numerous questions and controversies have beset efforts to promote behavior 
change. Because of sensitivities associated with human sexuality and drug use, many 
political and opinion leaders have shied away from open, frank discussion of how to 
change behaviors to prevent transmission. Widespread hostility toward the populations 
at greatest risk for infection has further undermined support for HIV prevention, and 
efforts to change behavior have frequently become ensnared in bitter ideological disputes.
While the epidemic has expanded over the past quarter-century, some have questioned 
whether it is possible to accomplish marked and sustained changes in behavior sufficient 
to alter the epidemic’s trajectory. The suggestion has been made that factors unrelated 
to prevention programming may account for the favorable behavior shifts seen in some 
countries. Moreover, recent years have witnessed an increase in risk behaviors in some 
settings where HIV prevention successes were first documented, calling into question 
the sustainability of favorable behavior shifts and highlighting the need for better 
understanding of how human behaviors might change in response to an ever-evolving 
epidemic.
In addition, HIV is no longer a new threat. There are doubts in some quarters about 
whether strategies or program models that may once have worked remain relevant in 
settings that have undergone important social and economic changes. Whether HIV 
prevention can remain effective as rates of HIV-related illness and death fall is a topic 
of debate in the HIV field. In addition, some commentators have argued that core HIV 
prevention strategies, such as condom promotion and treatment of sexually transmitted 
infections, are unlikely to significantly lower transmission rates in high-prevalence 
settings (see Potts 2008).
At the beginning of this decade, the global community embraced a set of ambitious 
development goals for the new millennium. Among these was the commitment to 
halt and begin to reverse the global HIV epidemic by 2015. Because behavior change 
remains the world’s primary tool for achieving this goal, clarity is urgently required 
regarding the optimal means of producing needed behavior changes. In particular, clearer 
understanding is needed regarding the best strategies to reduce the number of new 
( 8 )
Behavior Change  
and hiv Prevention: 
(Re)Considerations for the 21st Century
HIV infections in hyperendemic settings, where modest 
favorable changes in individual risk behavior are likely 
to have only limited effect due to such structural factors 
as partnership concurrency and gender inequity that 
magnify transmission risks associated with low levels of 
risk behavior.
This latest report by the Global HIV Prevention Working 
Group (PWG) focuses specifically on behavior change, 
surveying the evidence for behavioral HIV prevention to 
identify what is known and not known about generating 
and sustaining behavior change. The report describes 
the elements of successful behavioral initiatives, the 
limitations of current approaches, key outstanding 
questions, and research needed to strengthen the evidence 
base for behavior change. It ends with suggested next 
steps for moving forward with a clear and more focused 
strategy for using behavior change in HIV prevention 
efforts. 
Assessing the effectiveness of HIV prevention is 
intrinsically challenging. Understanding why something 
did not happen is typically more complicated than 
understanding an event or phenomenon that can be 
observed, studied, and measured. The totality of evidence, 
however, indicates that available HIV prevention 
strategies have the potential to significantly reduce the 
rate of new HIV infections—in all regions, among diverse 
populations, and at different stages of national epidemics. 
Indeed, available strategies have the capacity to achieve 
in the field of HIV prevention what antiretrovirals have 
accomplished in the clinical setting, as the parallels 
between HIV prevention and treatment are striking. Like 
antiretroviral therapy, HIV prevention is lifelong, and its 
impact must be continually monitored and the prescribed 
regimens revised as circumstances and needs change. Just 
as a single pill cannot eradicate HIV, one-shot prevention 
efforts will not achieve the magnitude or sustainability of 
behavior change required to alter the epidemic’s course.
Like treatment, effective HIV prevention requires a 
combination of strategies. Evidence-based approaches to 
prevent infection include programs targeting individual 
behavior; broad-based efforts to alter social norms and 
address the underlying drivers of the epidemic; and 
effective use of biomedical or technological tools, such 
as treatment of sexually transmitted infections (STIs), 
medical male circumcision, substitution therapy for 
chemical dependence, and programs that provide access 
to clean injecting equipment.
Behavior Change and hiv Prevention
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Behavior Change  
for hiv Prevention
Behavioral HIV prevention programs can target 
individuals, families, communities, entire societies, 
or (ideally) a combination of all these. Well-
designed programs seek to achieve results on 
multiple levels. They promote accurate individual 
knowledge and perception of risk and increase 
individual motivation to avoid risky behavior. 
Prevention programs also build individual skills 
needed to use prevention commodities properly 
and, to the extent feasible, to avoid or effectively 
negotiate risky situations. Within households, 
HIV prevention programs aim to decrease the 
stigma associated with both HIV and sexuality, 
to promote open discussion about sexuality and 
drug use, and to influence gender roles and norms. 
At a community level, effective programs seek to 
increase the value associated with safer behaviors, 
to support community members to reduce their 
risk, to build social solidarity and reciprocity, and 
to reinforce new norms.
Behavioral HIV prevention programs may also 
seek to achieve results at a broader social or 
structural level. Such approaches might include 
direct interventions that introduce prevention 
tools into particular environments (for example, 
mandating condom use in brothels), influence the 
physical environment (improving street lighting 
to reduce the likelihood of rape), expand clinical 
services (ensuring access to drug substitution 
therapy for chemical dependence), or create more 
supportive legal and policy norms (legalizing same-
sex relations). Social or structural interventions 
might also be indirect, by supporting broader 
efforts to improve the overall protection and 
promotion of human rights, to reduce income 
inequality, and to address gender inequities.
Individuals and groups might change behaviors in 
any number of ways—including some that may be 
detrimental to the cause of HIV prevention. When 
this report refers to behavior change, it intends to 
encompass only the range of behavior changes that 
reduce the risk of HIV transmission or otherwise 
promote the development of social, physical, and 
legal environments that are conducive to risk 
reduction.    
Like treatment, HIV prevention works best when it 
addresses individual needs and circumstances. In the case 
of treatment, different patients have different therapeutic 
needs and respond differently to therapy. Children 
and adults living with HIV require different doses of 
antiretroviral medications, and patients’ response to a 
particular regimen will depend in part on whether they 
have been exposed to any of the prescribed medications, 
and whether clinicians take care to avoid certain regimens 
for patients who have specific comorbidities. Likewise, 
effective HIV prevention acknowledges the complexities 
and needs of specific individuals and communities, 
eschewing cookie-cutter approaches that ignore the 
diversity of needs in the real world.
Comparable to treatment, HIV prevention will have 
an effect only if it reaches those who need it. Just as 
concerted global efforts have led to dramatic increases 
in access to antiretrovirals, similar efforts are required to 
bring evidence-informed HIV prevention approaches to 
scale. And as robust research efforts point the way toward 
newer classes of antiretrovirals, substantially stronger 
research is needed to address the gaps and limitations in 
existing prevention strategies. 
To be more effective in the 21st century, the HIV 
prevention effort must confront several challenges of 
perception: a misplaced pessimism about the effectiveness 
of behavioral HIV prevention strategies; the unfortunate 
confusion between the difficulty in changing human 
behavior and the inability to do so; and the misperception 
that just because it is inherently difficult to measure 
prevention success—a “nonevent”—prevention efforts 
have no impact. 
the ContinUing 
UrgenCy of hiv 
Prevention
In December 2007, UNAIDS and the World Health 
Organization (WHO) released updated estimates of 
prevalent and incident HIV infections worldwide. In 
2007, an estimated 33.2 million people were living with 
HIV, approximately 2.5 million people became infected, 
and 2.1 million people died (UNAIDS and WHO 2007). 
These estimates represent notable downward revisions of 
estimated global HIV prevalence and incidence. Based on 
the best available evidence, it now appears that the global 
epidemic stabilized in the late 1990s and that the annual 
number of new infections may have since modestly 
declined. 
Yet the dimensions and pace of the epidemic remain 
staggering. The news is especially dire in southern Africa, 
where little progress in curbing the rate of new infections 
has occurred outside Zimbabwe. HIV infections continue 
to increase in a number of countries, including China, 
Indonesia, Mozambique, Russia, Ukraine, Vietnam, and 
several high-income countries. 
The most recent evidence regarding the state of the global 
HIV epidemic leads to several conclusions: 
•  hiv pRevention Remains one of the woRld’s 
moSt imPortant PrioritieS. While substantial 
media attention focused on the lowering of global 
estimates of HIV prevalence as a result of improved 
epidemiological methods, the levels of infection 
and the human toll from the epidemic remain 
unacceptably large. a virus that was unknown 30  
years ago is the fourth leading cause of death  
globally (WHo 2003).  
•  the hiv epidemiC Continues to expand, 
and treatment aLone WiLL not reverSe 
it. because the number of new infections exceeded 
the number of aIDS deaths, the epidemic further 
expanded in 2007. the number of new infections was 
2.5 times greater than the increase in the number 
of HIV-infected individuals on antiretroviral therapy, 
underscoring the urgent need for more effective HIV 
prevention to preserve the future viability of treatment 
initiatives (u.n. Secretary-General 2008).
•  in sub-sahaRan afRiCa, wheRe the hiv 
buRden is heaviest, pRogRams foCusing on 
individUaL riSK Behavior are UnLiKeLy on 
their oWn to aChieve the LeveL of SUCCeSS 
needed to reverSe the ePidemiC. More than 
two out of three infections worldwide are in sub-
Saharan africa (unaIDS and WHo 2007). although 
individual behavior change programs and initiatives 
that target groups at highest risk retain an important 
place in the region’s HIV prevention continuum, 
meaningful reductions in HIV prevention levels will 
require major population-wide changes in social 
norms with regard to sexual and relationship norms 
and gender equity (see u.n. Secretary-General 2008).
•  in most CountRies outside sub-sahaRan 
afRiCa, pRevention effoRts should 
foCUS on PoPULationS at higheSt riSK of 
infeCtion. low national HIV prevalence frequently 
masks extremely high infection rates in key 
populations. In latin america, for example, where 
HIV prevalence is below 1 percent, an estimated 
one-third of men who have sex with men (MSM) are 
HIV-infected (baral 2007). Similarly high infection 
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rates are reported for sex workers, injection drug 
users (IDus), prisoners, mobile populations, and other 
vulnerable groups. although HIV is unlikely to become 
generalized in most countries with low overall HIV 
prevalence, the rapid spread of HIV in Russia, ukraine, 
Indonesia, and other countries is of grave concern. 
Preventing new infections in the most heavily affected 
populations represents a pressing public health and 
humanitarian imperative.
•  behavioR Change Remains the dRiving 
forCe for nationaL SUCCeSS againSt hiv. 
Clinical trial results in 2007 suggest that the timeline 
for major technological breakthroughs in the HIV 
prevention field is likely to be long. trials of the most 
promising HIV vaccine candidate were terminated in 
September 2007 due to lack of efficacy, and similarly 
disappointing results have recently been reported for 
early-generation microbicides (nelson 2007), female 
diaphragms (Padian 2007), and community-wide 
treatment for herpes simplex virus 2 (Watson-Jones 
2008). behavior change remains the primary tool for 
reversing national epidemics, as illustrated by recent 
experience in Zimbabwe, where population-wide 
changes in sexual behavior have resulted in marked 
declines in HIV prevalence and incidence (unaIDS 
2005a).
The countries most heavily affected by the epidemic have 
waited many years for signs of a decline in the number of 
new HIV infections, and emerging evidence of a modest 
fall in incidence over the last decade should be greeted 
with relief and optimism. Declining incidence, however, 
must not lull decision-makers or individuals at risk into 
believing that the epidemic is nearing extinction. While 
some epidemics expand, peak, and then decline into 
oblivion, this is not always the case, especially for sexually 
transmitted epidemics. The HIV epidemic has repeatedly 
upset authoritative projections, and additional surprises 
are likely. Disturbing increases in risk behaviors in Uganda 
and many high-income countries underscore the risk in 
relaxing prevention efforts following early signs of success.  
the evidenCe BaSe 
for Behavior Change 
for hiv Prevention
The scientific literature and documented national 
experience clearly demonstrate the effectiveness of HIV 
prevention in changing sexual and drug-using behaviors 
(see Prevention Working Group 2007). Notwithstanding 
the strong evidence base for HIV prevention, policy 
makers and affected communities still express a need for 
such information and/or misunderstand what is known. 
This section of the report summarizes the most recent 
available evidence on effective strategies for changing 
behaviors in order to prevent HIV, examining evidence 
on behavioral interventions derived from both clinical 
randomized controlled trials (RCTs) and observational 
epidemiology. 
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effeCtive hiv Prevention 
in hyPerendemiC SettingS
In countries with low HIV prevalence, most 
people are at low risk of contracting HIV even 
when engaging in unprotected sex. In such 
settings, the basic approach to HIV prevention is 
clear: concentrated HIV prevention for groups at 
elevated risk of infection, attention to potential 
epidemiological “bridges” between the general 
population and populations most at risk, and 
education, awareness, and anti-stigma measures 
for the population as a whole.
In hyperendemic settings,2 where high levels 
of HIV are present throughout the general 
population, even low levels of risk behavior often 
carry substantial risk of infection. In sub-Saharan 
Africa, at least 15 percent of the adult population 
in seven countries is infected. In such settings, the 
risk that one’s spouse will be HIV-infected, or that 
young people will encounter the virus the first time 
they have sex, can be considerable. Where the risk 
of infection is omnipresent, the discrete aims of 
HIV prevention in low-prevalence settings are not 
sufficient. 
In hyperendemic countries, nothing short of 
countrywide mobilizations will sufficiently address 
the epidemic’s threat. Where HIV is generalized, 
every workplace, school, and community setting 
must be used for intensive HIV prevention 
activities. HIV must become a natural and central 
topic of discussion, and new societal norms must 
be forged regarding gender relations and sexual 
behavior. 
2  Technically, HIV does not fit the usual epidemiological definition of a 
“hyperendemic disease,” in that it does not affect all age groups equally, even 
in the most heavily affected areas. The term, however, is convenient as a way 
to denote a country where HIV is widely prevalent throughout the general 
population. UNAIDS considers countries to be hyperendemic if their adult 
HIV prevalence exceeds 15 percent.
What is the Best Way to measure the 
effectiveness of hiv Prevention?
Assessing the effectiveness of HIV prevention programs 
is inherently difficult. As a threshold matter, determining 
what caused an event to never occur is intrinsically more 
complicated than discerning the cause of something 
that can be readily observed. In some countries where 
HIV prevalence has remained low, it is likely that HIV 
prevention played a role in promoting safer behaviors. 
With the exception of Senegal, however, where early 
adoption of strong prevention measures and a high rate 
of medical male circumcision appear to have averted 
a potentially serious epidemic (see UNAIDS 2001), 
efforts to ascribe continued low HIV incidence solely to 
prevention programming are not substantiated. For drugs, 
vaccines, and medical devices, the RCT is universally 
regarded as the gold standard for evaluating efficacy in 
a new product. Indeed, national regulatory authorities 
require clear evidence of a product’s safety and efficacy in 
RCTs before it can be approved for marketing. 
RCTs have similarly demonstrated the efficacy of a wide 
range of individual and small group interventions in 
reducing risky sexual and drug-using behaviors (Lyles 
2007; CDC 2001a). As explained below, however (see 
page 17), demonstration of efficacy under the controlled 
conditions of a clinical trial does not ensure that the same 
intervention will be effective in the real world, especially 
with respect to behavioral interventions that may be 
highly sensitive to social environment and to differences 
in the target population. 
Moreover, while RCTs will continue to have a role in 
HIV prevention research, especially with regard to 
the development of new prevention technologies, it is 
unclear whether such trials best gauge the effectiveness 
of behavioral interventions. RCTs are primarily a vehicle 
for evaluating biomedical interventions, rather than 
strategies to change human behavior. Altering the norms 
and behaviors of social groups can sometimes take 
considerable time, and such shifts may be difficult to 
capture by time-limited studies. In addition, quantifying 
the social effects that may ultimately contribute to broad-
based behavior changes may be difficult, and sometimes 
even impossible. 
To discern strategies that are effective, observational data 
on national responses and epidemiological or behavioral 
impact often provide the best information (see Hallett 
2007). Observational data are intrinsically more difficult 
to interpret than RCTs and cannot tie behavioral or 
epidemiological trends to particular actions. However, 
carefully studying national responses and contemporaneous 
behaviors helps clarify the array of factors that appear to 
contribute to population-wide shifts in behaviors. 
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pRioRitizing behavioR 
Change aS neW 
Prevention tooLS  
are introdUCed
The distinction commonly made between 
behavioral and biomedical tools for HIV 
prevention is a false one. Not only do behavior 
change programs depend on the existence 
of essential technologies—such as condoms, 
clean injecting equipment, and HIV testing 
kits—but biomedical tools will have limited 
impact in reducing new infections in the absence 
of supporting behaviors. The emergence of 
new biological tools to reduce the risk of HIV 
transmission offers potential opportunities to 
improve understanding of human behavior with 
respect to health-seeking and adoption of new 
health technologies.
Medical male circumcision is an example of the 
synergistic relationship between behavior change 
and biomedical prevention. Recent studies in 
Africa indicate that the surgical procedure can 
help reduce the risk of female-to-male HIV 
transmission by as much as 60 percent (Bailey 
2007; Gray 2007; Auvert 2005). As a result of 
these findings, medical male circumcision is 
now regarded as a core evidence-based HIV 
prevention strategy, with particular potency 
in the countries most heavily affected by the 
epidemic. The effectiveness of adult medical male 
circumcision depends, however, on appropriate 
behavioral responses to this potentially powerful 
new intervention. At-risk men must be persuaded 
to undergo the procedure, health-care providers 
and traditional practitioners must be convinced 
and properly trained to ensure the safety of the 
procedure, and men should avoid engaging in 
sexual intercourse before circumcision wounds 
are completely healed, before which the risk of HIV 
transmission may actually be accentuated. 
randomized Clinical trials:  
Changing individual Behavior3
Researchers have conducted clinical trials on a wide range 
of individual and small group interventions targeted 
to particular populations. Most such studies have been 
conducted in high-income countries and have involved 
interventions grounded in one or more cognitive 
behavioral theories.
A review of sexual risk reduction interventions found that 
all meta-analyses that examined condom use detected a 
significant increase in usage, and most studies also found 
a reduction in the incidence of unprotected sex. Among 
meta-analyses4 that studied the impact of interventions 
on the number of sex partners, fewer than half found a 
significant reduction. Most studies that tracked incidence 
of STIs detected a significant reduction following the 
behavioral intervention, although one-third found no 
significant effect (Noar 2008).
On the basis of peer-reviewed publications through 2004, 
the U.S. Centers for Disease Control (CDC) identified 42 
prevention models demonstrated to be efficacious in well-
designed studies (Lyles 2007; CDC 2001a). In each of the 
studies accepted by the CDC, trial participants exposed 
to the prevention model exhibited significant reductions 
in HIV risk behaviors in comparison with unexposed 
participants. Nineteen of the 42 “best practice” models 
identified by the CDC target heterosexual adults, 11 focus 
on young people, 10 aim to reduce risk behaviors of IDUs, 
and eight target MSM. Four of the most recent behavioral 
prevention models are specifically designed to reduce 
risky behaviors among people living with HIV. 
Meta-analyses have similarly found evidence of efficacy for 
behavioral models targeting populations at highest risk:
•  young people: among 22 studies of school-based 
prevention education programs in low- and middle-
income countries, 16 were determined by WHo and 
others to significantly delay sex, reduce frequency 
of sex, reduce number of partners, increase use of 
condoms or contraceptives, and decrease frequency  
of unprotected sex (WHo 2006).  
•  men who have sex with men: a meta-analytic 
review of well-designed studies of behavioral models  
targeting MSM in high-income countries found that  
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hiv Prevention 
effeCtiveneSS:  
the evidenCe from 
CLiniCaL triaLS of neW 
Prevention teChnoLogieS
In prevention trials, participants receive extensive 
state-of-the-art HIV prevention services, including 
HIV education, client-centered counseling, HIV 
testing, screening and treatment of sexually 
transmitted infections, and essential HIV 
prevention commodities, such as male and female 
condoms. Prevention messages are periodically 
reinforced, and receipt of standard prevention 
services is assured as long as the trial continues.
Researchers have long noted the remarkable 
effectiveness of HIV prevention in clinical 
trial settings. Indeed, due to the impact of HIV 
prevention services in lowering HIV incidence, it 
is widely agreed that future prevention trials may 
need to be much larger than in the past in order to 
have sufficient statistical power. 
This was recently quantified by investigators in 
the previously referenced MIRA trial, which found 
that the combination of a female diaphragm and 
lubricant provided no additive prevention benefit 
beyond condoms (Padian 2007). Interviews with 
trial participants conducted 14 months following 
participation documented the impact of ongoing 
receipt of HIV prevention services. While 82 
to 84 percent of sex acts involving MIRA trial 
participants involved use of a condom during the 
study, only 57 percent of such acts were protected 
14 months after trial participation. Whereas 64 to 
67 percent of study participants reported consistent 
condom use during the trial, barely one-third (35 
percent) regularly used a condom 14 months after 
the trial (Padian 2008).
Experience in clinical trials demonstrates that the 
regular delivery of evidence-based HIV prevention 
services is highly effective in changing individual 
behavior. While it may not be feasible to replicate 
the intensity of prevention services in most non-
trial settings, the record in the prevention research 
field indicates that greater investment in evidence-
based prevention services would yield favorable 
behavioral results.  
3  The National Institutes of Health defines a randomized controlled trial as “a 
prospective experiment in which investigators randomly assign an eligible 
sample of patients to one or more treatment groups and a control group and 
follow patients’ outcomes” (National Library of Medicine 2007).
4  Meta-analyses analyze multiple studies to assess key findings across a large body 
of data and to discern the weight of scientific evidence on a particular question.
MSM-targeted prevention programs reduced the odds 
of reported unprotected anal intercourse by 27 to 
43 percent. Group-level interventions increased the 
chances of condom use by 81 percent among MSM 
studied (Herbst 2007). 
•  sex woRkeRs: a meta-analysis of 62 well-designed 
evaluation studies (44 from sub-Saharan africa and 
18 from asia) found that behavioral models targeting 
sex workers significantly increased condom use 
with clients, although these programs had only 
limited impact on condom use with casual partners. 
the prevention models had no significant effect on 
condom use in marital or steady relationships, except 
in the case of couples in which one partner had been 
diagnosed as HIV positive (Foss 2007).
•  injeCtion dRug useRs: In a meta-analysis of data 
on IDus in new York City, researchers determined 
that nonparticipants in harm-reduction programs 
were 3.5 times more likely to become HIV-infected 
than participants (DesJarlais 1996). Multiple 
studies conducted in resource-limited settings have 
confirmed the public health benefits of harm reduction 
programs (Institute of Medicine 2006; Wodak and 
Conney 2006). numerous behavioral models have 
demonstrated efficacy in reducing HIV risk behaviors 
among IDus (lyles 2007; CDC 2001a), although such 
programs have had greater success in influencing 
drug-using behaviors than in altering sexual risk 
behaviors of IDus (see lindenburg 2006).  an analysis 
of study results on 33 different behavioral models 
targeting IDus found that individuals exposed to 
such interventions were 12.6 percent more likely to 
reduce risk behaviors (Semann 2002). Receipt of drug 
substitution therapy or other drug treatment also 
reduces drug-using behavior and lowers the risk of 
HIV transmission (Zaric 2000).
observational epidemiology:  
evidence of national Success 
Countries in diverse regions and of different income levels 
have markedly lowered the rate of new HIV infections. In 
all such cases, favorable epidemiological trends were the 
result of major shifts in human behavior.
•  austRalia: Much sooner than the united States 
and some other high-income countries, australia 
mounted a visible, well-supported national aIDS 
response beginning in the early 1980s. early initiatives 
included broad public-awareness campaigns, focused 
behavioral interventions for gay men, public-sector 
support for needle and syringe exchange, and 
voluntary HIV counseling and testing (bowtell 2005). 
Dramatic declines in unprotected anal intercourse 
and the sharing of needles for drug use were recorded 
(national Centre in HIV epidemiology and Clinical 
Research 1995). as a result of australia’s early, 
comprehensive response, focused largely on behavior 
change, annual HIV incidence peaked in 1985 and 
declined through the end of the 1990s. between 1990 
and 2000, the annual number of new HIV diagnoses 
fell by half (national Centre in HIV epidemiology and 
Clinical Research 2007). 
•  bRazil: like australia, brazil encouraged open 
discussion of HIV, supporting frank public-awareness 
campaigns, condom promotion, focused behavioral 
interventions, syringe and needle exchange, school-
based HIV education, prevention services in prisons, 
and voluntary HIV counseling and testing. especially 
noteworthy is brazil’s success in reversing a serious 
epidemic among IDus. Condom use increased by 
almost 50 percent among sexually active adults 
between 1998 and 2005, and focused behavior change 
Behavior Change and hiv Prevention 
( 14 )
hiv Prevention in the era 
of exPanded treatment 
aCCeSS
Although each episode of HIV transmission 
requires the participation of an individual living 
with HIV, prevention efforts have historically 
focused on individuals who are HIV uninfected or 
unaware of their HIV serostatus. This represents 
a significant gap in prevention efforts, because 
people living with HIV have a potentially 
critical role to play in reducing the risk of HIV 
transmission.  
Including people living with HIV in prevention 
efforts offers a potentially important avenue to 
further bolster the effectiveness of HIV prevention. 
In high-income countries, where combination 
antiretroviral therapy has been widely available 
for more than a decade, notable efforts have been 
made to develop and implement prevention 
programs specifically tailored for people living with 
HIV. According to early studies, such “positive 
prevention” programs show promise in promoting 
safer behaviors among HIV-infected people 
(Crepaz 2006). 
As HIV testing initiatives expand, especially in 
developing countries where HIV treatment access 
is on the rise, knowledge of HIV serostatus will 
become more widespread, potentially permitting 
better serostatus targeting of prevention messages 
and programs. HIV clinical settings offer an 
especially important venue for the delivery of HIV 
prevention services for people living with HIV 
(Prevention Working Group 2004).
prevention programs also maintained HIV prevalence 
at low levels among sex workers (okie 2006). although 
the World bank had predicted in 1990 that 1.2 million 
brazilians would be infected by 2000, fewer than 600,000 
were living with HIV in 2002 (Ministry of Health 2003).    
•  thailand: In response to an increase in infections 
in the late 1980s, thailand initiated an innovative 
national program that has served as a model for 
other countries. the country’s 100 percent condom-
usage program promoted condom use in brothels, 
and national leaders encouraged discussion of the 
HIV threat and the fair treatment of those who were 
infected (unaIDS 2001). as a result of the country’s 
energetic support for HIV prevention, condom rates 
increased, while the percentage of men visiting 
brothels declined. annual HIV incidence declined from 
143,000 in 1991 to 19,000 in 2003, helping reverse 
what was once one of the world’s fastest-growing 
epidemics. Had thailand not brought comprehensive 
HIV prevention to scale, it would now have 7.7 million 
HIV infections, rather than the estimated 580,000 
residents currently living with HIV (Ravenga 2006; 
unaIDS 2006).
•  uganda: In what is perhaps the world’s best-
documented national prevention success, uganda 
moved in the mid-1980s to address the rapid spread of 
HIV, implementing public-awareness campaigns that 
encouraged young people to delay initiation of sex and 
urged sexually active adults to reduce the number of 
sex partners. In the 1990s, the country supplemented 
these early measures with condom promotion and 
investment in voluntary counseling and testing. From 
the earliest years, community-generated programs 
played a major role in the country’s aIDS response.  
the results of these efforts were remarkable. the  
percentage of young people who were sexually 
active fell by more than half between 1989 and 1995, 
and ugandans were significantly less likely to have 
multiple sex partners than people living in neighboring 
countries (unaIDS 2001). Increases in condom use 
in the 1990s helped preserve and accelerate early 
prevention gains (uSaID 2002). by the late 1990s, 
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BehavioraL interventionS to enhanCe the SUCCeSS of 
pRogRams to pRevent motheR-to-Child hiv tRansmission
Implementation of a package of prevention 
services—including routine voluntary HIV testing 
and counseling, timely antiretroviral prophylaxis, and 
breast-feeding alternatives—has sharply lowered the 
rate of mother-to-child HIV transmission in high-
income countries. In 2006, only 13 children were 
diagnosed with HIV in New York City (New York City 
Department of Health and Mental Hygiene 2007), while 
in the same year only 191 children contracted HIV 
infection in all of western Europe (EuroHIV 2007).
Considerable progress has also been achieved in the 
past two years in expanding access to prevention 
services in antenatal settings in low- and middle-
income countries. Globally, the percentage of HIV-
infected pregnant women who received antiretroviral 
prophylaxis rose from 14 percent in 2005 to 34 percent 
in 2007. In a number of countries—including the 
Bahamas, Botswana, and Thailand—coverage now 
exceeds 80 percent. In Botswana, the provision of 
evidence-based prevention services in antenatal settings 
has lowered the transmission rate for newborns born  
to HIV-infected mothers from 30 to 40 percent to 
under 4 percent (U.N. Secretary-General 2008).
While remarkable, these gains are not uniformly 
evident. Global coverage, for example, is well shy of 
the 80 percent target to which U.N. member states 
agreed in the 2001 Declaration of Commitment on 
HIV/AIDS, which was unanimously endorsed at the 
first-ever U.N. General Assembly Special Session on 
HIV/AIDS.
Although prevention of mother-to-child transmission 
relies in large part on a biomedical intervention 
(antiretroviral prophylaxis), human behavior is 
essential to prevention success. Prevention efforts 
depend on health-care workers to routinely offer 
testing to their patients in antenatal settings and on 
pregnant women to accept HIV testing, adhere to 
prophylactic regimens (both for themselves and for 
their newborn), adopt recommended procedures for 
infant feeding (typically exclusive breastfeeding for a 
short period), and return their infants for follow-up 
testing and monitoring. 
Primary HIV prevention for women is also central to 
the long-term success and sustainability of prevention 
of mother-to-child transmission. The Elizabeth Glaser 
Pediatric AIDS Foundation, which provides services 
to prevent mother-to-child transmission at 2,800 
sites worldwide, reports that HIV prevalence among 
pregnant women has steadily declined in most of the 
13 African countries studied (Amouzou 2007).
infection levels in capital city kampala had fallen by 
two-thirds, and national HIV prevalence had been cut 
in half (unaIDS 2002).5
These countries are not alone in the progress they have 
achieved in reducing new HIV infections through broad- 
based behavior change. Cambodia, Zimbabwe, and others 
have seen similar declines in HIV prevalence following 
significant shifts in sexual behaviors. In the case of 
Senegal, early investment in awareness-raising, condom 
promotion, intensive prevention services for populations 
at greatest risk, and engagement of community leaders 
and faith-based organizations, combined with high 
rates of medical male circumcision, succeeded in 
keeping national HIV prevalence below 1 percent, when 
neighboring countries experienced significant increases in 
infections (UNAIDS 2001).  
Unlike controlled efficacy trials, observational 
epidemiology cannot definitively establish a causal 
link between HIV prevention and declines in new HIV 
infections. Yet together, these examples suggest that 
countries in a wide variety of settings have contributed 
to changes in HIV risk behaviors and, in doing so, have 
saved countless lives by averting HIV transmission. Based 
on the totality of epidemiological evidence, it appears 
that national implementation of evidence-informed 
combination HIV prevention efforts in the 1990s was 
associated with a 50 to 90 percent decline in HIV incidence 
and prevalence in key populations (Auerbach 2006).          
What available data Say: Common 
attributes of Successful Behavioral 
Prevention Programs
The record on effective HIV prevention, as derived 
primarily from national experience but also supported 
by RCTs on discrete interventions, reveals that successful 
programs share certain basic characteristics:
•  Combination pRevention: effective HIV 
prevention involves the simultaneous use of diverse 
prevention strategies—programs that help individuals 
prevent transmission, broader-based initiatives that 
alter the norms and behaviors of social groups, and 
increased access to tools that reduce the biological 
likelihood of transmission (for example, StI treatment 
and medical male circumcision).6 
•  ensuRing pRopeR sCale: to achieve optimal 
public health impact, the appropriate combination 
of evidence-based HIV prevention strategies must 
achieve sufficient coverage, intensity, and duration to 
have optimal public health impact. 
•  affeCting knowledge, attitudes, pRaCtiCes, 
and BehaviorS: accurate knowledge about HIV, 
although critical, often does not lead on its own to 
sustained behavior change. effective HIV prevention 
helps individuals perceive whether they might be at 
risk for HIV, increases the motivations and intentions 
to reduce risk, and builds the skills required to enable 
individuals to protect against transmission.    
•  Changing soCial noRms: effective HIV prevention 
addresses the social dynamics that influence 
individual behavior. In places where changes in 
community norms have occurred to promote HIV 
prevention, diverse strategies appear to have played 
a role in the favorable results. these include social 
marketing; mass-media campaigns, use of celebrities, 
faith-based groups, and opinion leaders to promote 
new norms; and other interventions designed to 
operate at a community level. 
•  ensuRing aCCess to hiv pRevention 
teChnoLogieS and CommoditieS: Globally, 
prevention efforts have prioritized ready access 
to condoms, while focused prevention efforts for 
drug users have facilitated the provision of sterile 
injection equipment. In the case of condoms, extensive 
marketing efforts have promoted them and addressed 
potential impediments to use, such as the perception 
that sex is no longer enjoyable when condoms are used. 
•  speCifiCity to Context: efforts to change 
behavior will be successful only if they resonate with 
the intended audience and address the specific needs 
and values of the focus population. While it is possible 
to distill certain principles from diverse experience 
globally, and is sometimes feasible to adapt model 
programs in diverse settings, experience teaches 
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5  For a discussion of more recent, less favorable epidemiological and behavioral trends in Uganda, see p. 18.
6  Use of a combination of prevention strategies is common to most successful health promotion efforts, including those not focused on HIV prevention. For example, recent 
research has found that malaria prevention uptake is greater when free bed-net distribution is supported by social marketing (Fegan 2007). With respect to injury prevention, 
declines in incidence occurred following the implementation of a combination of measures, including public awareness campaigns, initiatives to change social norms, and policy 
initiatives to regulate or prohibit unsafe behaviors and to improve safety engineering of products or environments (see Wohlfeiler and Ellen 2007).
  The history of antismoking campaigns in high-income countries is similarly illustrative. In the United States, for example, a broad array of strategies have been pursued to 
reduce tobacco intake: extensive public-awareness campaigns in the mass media, school-based antismoking programs, concerted efforts to alter social norms and attitudes 
regarding smoking, policy changes (for example, prohibiting or regulating smoking in public places, increasing cigarette taxes), technological innovations (for example, nicotine 
replacement therapies), and litigation to hold cigarette companies accountable for the medical expenses associated with smoking. These strategies have combined to reduce by 
more than half the percentage of adults who smoke tobacco products over the last 40 years (CDC 2007). While few would claim or expect that any element of this decades-long 
public health initiative was single-handedly responsible for the dramatic decline in smoking in the United States, this has often been the methodological approach taken to date 
with respect to measuring the impact of behavioral HIV prevention.
that prevention efforts need to be specific to the 
geographic and social context in which risk behavior 
occurs (unaIDS 2005b).
In addition to these program characteristics of successful 
HIV prevention efforts, national experience has 
underscored the importance of certain environmental 
factors that contribute to the effectiveness of prevention 
programs:
•  Community leadeRship: to produce strong 
and sustained behavior change, communities must 
own the response and help lead efforts to change 
behavior (Campbell 2003; see barnett and Whiteside 
2006; bowtell 2005). In the countries where HIV 
prevention has been most successful, communities 
have been active participants in the development, 
implementation, and oversight of prevention efforts.    
•  politiCal leadeRship: Few countries have 
substantially lowered HIV infection rates without 
strong, sustained, and high-level political leadership. 
leadership from the highest political levels helps 
attract needed resources for prevention efforts and 
encourages the engagement of multiple ministries 
and sectors in the HIV response.
•  enCouRaging open disCussion of hiv: Where 
population-based behavior changes have driven long-
term declines in HIV infection, the epidemic has been 
a topic of open discussion and debate (unaIDS 2001). 
bringing HIV into the light of day enables individuals to 
perceive their own risk and facilitates the development 
of new social norms.   
•  RespeCting human Rights and alleviating 
hiv Stigma: In countries with successful HIV 
prevention records, lawmakers have enacted strong 
legal protections against HIV-based discrimination 
(see okie 2006; unaIDS 2001). Respecting the human 
dignity of the target population is especially critical in 
reaching socially marginalized groups with effective 
HIV prevention services (Campbell 2003). basing HIV 
prevention efforts in human rights encourages frank 
discussion of HIV, engagement in HIV prevention 
activities, and knowledge of HIV serostatus. 
LimitationS to 
evidenCe BaSe and 
imPLementation 
of BehavioraL hiv 
Prevention
Although evidence demonstrates that it is possible 
to change human behavior to reduce the risk of HIV 
transmission, the evidence base on behavioral HIV 
prevention has important limitations. Policy makers and 
program implementers should take these limitations into 
account, especially when selecting strategies to implement 
in concert with specific behavioral strategies. 
translating efficacious Prevention models 
into effective, broad-based programs   
The difficulty of ensuring that efficacious interventions 
are effective in the real world is not unique to behavioral 
strategies. Even for well-characterized biomedical 
interventions, it is sometimes difficult to replicate in the 
field the degree of success achieved in clinical trials.7 
RCTs for behavioral program models typically fail to 
replicate the conditions under which such services 
will be delivered in the real world. For example, most 
RCTs recruit only from populations that are carefully 
defined, yet the universe of individuals at risk of HIV 
infection is extraordinarily diverse. Comparatively few 
behavioral models have been validated in RCTs for use 
in many of the populations at highest risk, including 
IDUs, MSM, and sex workers.8 The poor correlation 
between behavioral RCTs and the real world reduces the 
confidence of program planners in basing prevention 
strategies on the scientific literature.  
Moreover, many of the behavioral models validated in 
RCTs cannot feasibly be implemented in most settings. 
Among the CDC’s “best practice” models, program 
protocols provide for as many as eight sessions, with time 
commitments for participants ranging up to 32 hours, 
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7  There are many reasons for the gap between the results of clinical trials and experience in the field for therapeutic interventions. Clinical trial participants often receive a level 
of care and support that is seldom achieved in busy real-world health-care settings, potentially affecting treatment adherence, side effect management, and patient motivation. 
Moreover, RCTs may fail to attract participation by a large number of individuals who experience problems that may interfere with protocol adherence, such as active substance 
addiction, acute mental illness, and homelessness. 
8  Moreover, especially when the worldwide breadth of the epidemic is noted, it is apparent that key populations that appear unitary for epidemiological purposes are sociologically 
quite diverse. Interventions whose efficacy has been validated for MSM in Amsterdam or San Francisco, for example, may be wholly inapplicable in settings where same-gender 
sexual expression is more highly stigmatized and is the subject of severe criminal penalties. Similarly, interventions that aid opiate users to alter risky drug-using behaviors may 
be entirely ineffective for individuals who are dependent on stimulants. And brothel-based behavioral interventions for sex workers may be ineffective—and perhaps entirely 
unfeasible—for sex workers who do not work in brothels.
inherently limiting the number of individuals at risk who 
are willing to seek and complete the intervention (see 
Lyles 2007; CDC 2001a). The cost per infection averted 
for such high-intensity prevention programs may render 
them unaffor urden countries
Sustaining Behavior Change  
over the Long term
Few RCTs have followed recipients of behavioral HIV 
prevention models longer than 12 months, with many 
studies reporting follow-up periods as short as three 
months (see Lyles 2007; CDC 2001a). Emerging evidence, 
however, suggests that favorable behavior changes 
seen in the first year following an intensive behavioral 
intervention might not be sustained.
For example, trials of 10-week individualized counseling 
for MSM initially found significant behavioral benefits, 
as well as reduced HIV incidence, as a result of the 
intervention. Yet after 3.25 years, recipients of the 
program did not differ significantly from the control 
group with respect to HIV incidence. Analysis determined 
that initially favorable behavior changes dissipated after 
12 to 18 months, with the earlier beneficiaries of the 
program eventually reverting to riskier behaviors (Coates 
In press). 
Population-level behavior changes also sometimes fade 
over time. In Uganda, the single most impressive success 
story in forging new social norms and behavior patterns 
for HIV prevention, recent surveys have detected an 
increase in sexual risk behavior (UNAIDS 2007). Among 
MSM in the United States, dramatic changes in sexual 
behavior and similarly sharp declines in HIV incidence 
occurred in the 1980s following the implementation 
and strengthening of community-based HIV prevention 
efforts (see CDC 2006), yet rates of both unprotected 
anal intercourse and new HIV infections have notably 
increased among American MSM (Task Force on 
Community Preventive Services 2007).
There are many reasons why initial HIV prevention 
success in a country or population might not be sustained. 
Prevention efforts may not be reinforced or adapted over 
time, and the targets of prevention programs may develop 
“prevention fatigue,” making them less inclined to heed 
prevention messages and take appropriate precautions 
against the risk of transmission. Perhaps most important, 
individuals who are initially influenced by prevention 
programs are replaced over time by new population 
cohorts, who were not exposed to early prevention efforts 
and whose values, expectations, and social surroundings 
may be quite different.     
In addition, changes may occur in the underlying physical 
or social environment that undermine the effectiveness 
of once-successful prevention strategies. For example, the 
emergence of highly effective treatments has made HIV 
seem less serious to some, leading to an increase in risk 
behaviors. According to studies in a variety of groups in 
high-income countries, optimism regarding prospects 
for the treatment of HIV is associated with greater sexual 
Behavior Change and hiv Prevention 
( 18 )
doCUmenting and 
BUiLding on indigenoUS 
hiv Prevention SUCCeSSeS
In countries throughout the world, some of the 
most important prevention successes have been 
achieved by communities themselves, often 
working without external funding, institutional 
support, or strong partnerships with researchers. In 
the United States, for example, evidence indicates 
that radical behavior changes among MSM 
began occurring in the early 1980s, years before 
public funding was available for HIV prevention 
services in urban gay communities (see Vu 2002). 
While the Cambodian government has rightly 
been lauded for its leadership in implementing 
evidence-informed HIV prevention strategies, 
studies similarly suggest that behavior changes 
and declines in HIV incidence began prior to these 
actions by public health activities (Morineau 2006).
Community engagement is critical to creating 
broad-based demand for HIV prevention services. 
In every country in which HIV incidence has 
sharply declined, prevention efforts have been built 
on community mobilization and leadership (see 
Piot In press).
The indigenous community dynamics that promote 
leadership and innovation in HIV prevention are 
poorly understood. As a general rule, prevention 
researchers and public health authorities have 
directed only limited effort toward documenting 
and studying community-developed risk reduction 
strategies, opting instead to focus research resources 
on researcher-developed, theory-based behavioral 
interventions. This represents an important step in 
prevention research efforts. 
risk-taking (Grémy and Beltzer 2004; Tun 2003; Suarez 
2001; Kelly 1998). 
Moreover, the epidemic may evolve in ways that reduce 
the public health impact of previously successful 
prevention strategies. In Thailand, where the national 
epidemic was long concentrated among sex workers and 
their clients, nearly half of all new HIV infections are 
among heterosexuals with no history of intercourse with a 
sex worker.
Limited impact of individual  
Behavior Change
Existing models of behavioral interventions are based 
on various cognitive behavioral theories that assume 
individuals will take steps to avoid risks if they are 
fully informed and sufficiently motivated.10 While such 
approaches may work well for many people, they are 
unlikely to address the needs of the myriad populations 
at risk of infection. Because human sexuality and drug 
dependence are phenomena that are not always subject 
to cognitive control or mediation, cognitive approaches 
alone will not produce behavior change in many people.
Moreover, many individuals confront exceptionally 
elevated risk of infection not primarily as a result of their 
own risk behavior, but rather because of the behavioral 
characteristics of their partners or the particular structure 
and functioning of the social networks to which they 
belong. Influencing individual behavior in such cases will 
have only a limited impact on infection rates.
Examples of this paradox of high risk in the context of low-
risk behavior are numerous. Although heterosexuals in 
Africa are no more sexually active than their counterparts 
in other regions and are no more likely to have multiple 
partners, the region has the world’s most severe HIV 
epidemic, driven primarily by heterosexual intercourse 
(Wellings 2006). Similarly, while young African-American 
MSM are 4.5 times more likely to be infected than young 
white MSM (CDC 2001b), surveys indicate that they are 
less likely to have unprotected anal intercourse than their 
white counterparts (Crosby 2007; Millett 2006). 
To reduce new infections in such cases, HIV prevention 
must alter social norms or the functioning of social 
networks. In general, however, relatively few validated 
prevention strategies operate at a community level. 
Likewise, the evidence base for HIV prevention includes 
comparatively few policy (or structural) interventions 
that aim to reduce risk by altering the social, legal, or 
physical environments in which risk behavior may occur 
(Wohlfeiler and Ellen 2007; see Blankenship 2000).11 
With respect to relationships or social networks 
with characteristics that increase collective risk, HIV 
prevention initiatives must persuade social groups to 
examine and alter long-established values, assumptions, 
and behavioral patterns. There is growing recognition, 
for example, of the role of concurrent partnerships in 
facilitating the rapid spread of HIV, especially in endemic 
settings (Epstein 2007; Halperin and Epstein 2007; 
Morris and Kretzschmar 1997). To disrupt the dynamics 
of transmission in many high-prevalence countries in 
Africa, programs are needed that alert individuals to the 
risks associated with concurrency and that forge new 
social norms that reduce the frequency of concurrent 
partnerships.    
limited impact of one-dimensional 
Prevention evaluations and Programs 
All too often, both prevention research and prevention 
practice convey the belief that individual interventions 
or partial approaches have the capacity on their own 
to sharply reduce the number of new HIV infections. 
Truncated or partial approaches to HIV prevention 
inevitably fail to achieve optimal public health impact.
As an example of this mind-set, most prevention-efficacy 
trials to date have examined discrete programmatic 
models, such as individual or small group interventions, 
particular counseling protocols, or social-marketing 
campaigns for condoms. Few prevention trials have 
evaluated the impact of a combination of strategies 
designed to reduce unsafe behavior. This can lead to 
questionable programmatic decisions. For example, 
conflicting research findings on the impact of STI control 
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9  (UNAIDS 2004. data.unaids.org/Topics/Epidemiology/Slides12/bkk04slide004_en.ppt). 
10  These prevention models are based on one or more theories of individual behavior, including the health belief model (Rosenstock 1994), social-cognitive or social-learning theory 
(Bandura 1986), theory of reasoned action (Fishbein 1967), theory of planned behavior (Ajzen 1985), the AIDS risk reduction model (Catania 1990), the information-motivation-
behavioral skills model (Fisher 1994), and the stages of change (Prochaska 1994).
11  In addition to failing to address the impact of broader social networks, an exclusively individualistic approach to HIV prevention may also overlook the intrinsically social nature 
of sexual HIV transmission. For example, serodiscordant partnerships may account for a considerable share of new infections in some countries (see Wawer 2005). By focusing 
behavioral interventions on individuals rather than couples, HIV prevention efforts may be missing strategic opportunities to prevent transmission.
on HIV incidence (see Hitchcock and Fransen 1999) 
have led in some quarters to a de-prioritization of STI 
control as a key component of comprehensive HIV 
prevention. Similarly, ambiguous findings on the effect 
of HIV counseling and testing on HIV incidence have 
occasionally led to an academic discourse that suggests 
that HIV testing has little, if any, role in HIV prevention. 
The truth is that both STI treatment and HIV testing 
play a vital role in comprehensive HIV prevention, and 
each tends to be offered in the real world in conjunction 
with other services. Expecting either approach to achieve 
on its own the desired outcome for comprehensive HIV 
prevention may lead to an erroneous de-prioritization of 
important components of the prevention continuum. 
Vigorous debates have sometimes divided policy makers 
and program implementers in recent years regarding 
the relative importance of the various components of 
the “ABC” model (Abstain from sex; Be faithful to your 
partner; Condom use if necessary). This discourse, too, 
reflects the belief that a single key to HIV prevention can 
be discerned (see Wellings 2006). In the words of one set 
of commentators, these debates over the ABC approach 
infantilize HIV prevention by reducing human sexuality 
to a game of alphabet soup (see Collins 2008). The reality 
is that no single HIV prevention model—even one as 
supposedly multifaceted as ABC—can meet the broad 
array of HIV prevention needs. While ABC might work 
for some, it is most certainly unworkable for others, such 
as adolescent girls in Africa, whose primary risk factor 
is often early marriage to an older, HIV-infected partner 
(Bearinger 2007). 
The ABC debate reflects a counterproductive tendency 
of many policy makers to conceive of HIV prevention 
in paradigmatic terms. In reality, sexual and drug-
using behaviors are inevitably complex, diverse, and 
individually specific, dooming prevention strategies 
founded on a single paradigm or theory of behavior 
change. Different people will have different needs and 
require different approaches, and these needs and 
requisite strategies may evolve over time. Efforts to reduce 
behavior change to a sound bite or simple formula are 
bound to fail.
poor implementation of evidence-
informed hiv Prevention
Even the best HIV prevention strategies will have little 
impact if they are not properly implemented. A major 
reason why only limited behavior change has been 
achieved for HIV prevention is that few people at risk have 
access to the most basic prevention strategies. The vast 
majority of HIV-infected people worldwide are unaware 
of their HIV status, and most young people lack basic 
knowledge about HIV (U.N. Secretary-General 2008).
The lack of zeal for HIV prevention is especially evident 
when compared with the inspiring and energetic 
support in recent years for HIV treatment scale-up. 
Even in countries that have dramatically scaled up HIV 
treatment, HIV prevention coverage often continues to 
lag, due in part to poor national leadership. Of the nearly 
100 countries that have established national targets for 
universal access to HIV prevention, treatment, care, 
and support, twice as many countries have targets for 
antiretroviral treatment as for programs to achieve 
behavior change for HIV prevention (UNAIDS 2007).    
In many cases, national programs and international 
donors have failed to heed the scientific evidence on 
behavior change, supporting approaches that have little or 
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addreSSing the 
epidemiC’s undeRlying 
driverS in hyPerendemiC 
SettingS
Ultimately, addressing the paradox of elevated 
risk in the context of low-risk behavior will 
require concerted attention to the social factors 
that increase HIV risk and vulnerability (Barnett 
and Whiteside 2006; Parker 2000). This is 
especially critical in hyperendemic settings, 
where the generalized nature of the epidemic 
poses extreme risks to individuals who have 
low levels of risk behavior (Southern Africa 
Development Community 2006). Such social 
determinants of risk and vulnerability include 
gender inequities, institutionalized discrimination, 
and economic inequality (Piot 2007). Effective 
intervention to address such factors requires 
a combination of initiatives to change social 
norms (regarding intergenerational sex, gender 
violence, and the like), legal and policy reforms, 
and programmatic initiatives (such as recognition 
of women’s property rights, universal education, 
antidiscrimination laws, and schemes regarding 
social insurance, cash transfer, and microcredit). 
no evidence of effectiveness. For example, national leaders 
have often given limited priority to comprehensive HIV 
prevention for young people, opting instead for programs 
that promote abstinence as the sole means of avoiding 
infection (Corno and de Walque 2007). Yet studies in 
high-income countries indicate that youth-oriented 
prevention programs that exclusively promote abstinence 
do not reduce the risk of HIV infection (Underhill 2007).   
The failure of many countries to embrace harm-
reduction programs for IDUs is similarly illustrative of 
a failure to abide by available evidence documenting the 
effectiveness of such programs in reducing HIV infections 
(see Institute of Medicine 2006). Among 12 countries 
studied in 2007 by a task force of the Center for Strategic 
and International Studies, six had no drug substitution 
therapy. In four of the countries where maintenance 
therapy was technically available, it reached less than 5 
percent of those in need (Fiellin 2007). 
Even when countries desire to base national AIDS 
responses on the best available evidence, they often lack 
basic information about the nature and trends of their 
own epidemics. In many countries, health surveillance 
systems are weak, and national strategies are frequently 
drafted without a clear understanding of the populations 
at greatest risk, key infection trends, and the social factors 
that are driving the spread of HIV. By understanding the 
rate, location, and demographic characteristics of the past 
1,000 infections, national prevention planners would be 
better equipped to employ limited prevention resources 
most strategically. Improved epidemiological methods 
exist to permit a better, more timely understanding of key 
trends in national epidemics (Gouws 2006), but countries 
will require substantial additional capacity and targeted 
financial and technical assistance to implement these 
approaches.   
reCommendationS  
for aCtion
To ensure implementation of the HIV prevention 
strategies proven to be effective—and to address 
the gaps and limitations in the HIV prevention tool 
kit—the Prevention Working Group recommends the 
following to key stakeholders.
reCommendationS for 
PoLiCy maKerS for 
nationaL aUthoritieS 
and governmentS
•  sustain high-level politiCal suppoRt: 
Political leaders should energetically and visibly 
lead national HIV prevention efforts. High-level 
political support for HIV prevention should be 
sustained even after signs of success emerge.
•  pRioRitize hiv pRevention in national 
StrategieS: national aIDS plans should provide 
for a comprehensive, simultaneous scaling up 
of both HIV prevention and treatment. national 
HIV prevention efforts should be comprehensive, 
supporting the full array of evidence-informed 
prevention strategies that suit their national 
epidemic, including but not limited to condom 
promotion, StI control, programs promoting 
voluntary knowledge of HIV serostatus, harm 
reduction programs, behavioral interventions 
for populations at highest risk of infection, and 
initiatives that address gender-based violence and 
other aspects of gender inequities that influence HIV 
risk and vulnerability. especially in high-prevalence 
settings, prevention efforts should seek to persuade 
individuals to reduce the number of sexual partners 
and avoid concurrent partnerships.
•  establish and monitoR national taRgets: 
as part of their establishment of targets for 
universal access to HIV prevention, treatment, 
care, and support, national HIV authorities should 
establish and disseminate concrete goals for 
coverage, intensity, and impact of HIV prevention 
efforts. Working with international technical 
agencies, national HIV authorities should assess HIV 
prevention scale-up on an ongoing basis and identify 
factors that impede program expansion.
•  gRound the aids Response in human 
rightS: all countries should have in place strong 
and well-enforced laws that prohibit discrimination 
on the basis of real or perceived HIV status or of 
membership in a population at elevated risk of HIV 
infection. 
Behavior Change and hiv Prevention
( 21 )
•  impRove national infoRmation 
SyStemS: available data, derived from 
a thorough assessment of national and 
subnational epidemic dynamics, should 
help guide national decision-making on 
allocating prevention resources among 
different program components. to make an 
evidence-based approach to national strategic 
planning possible, countries, with assistance 
from technical agencies and donors, should 
build, strengthen, and maintain strong HIV 
monitoring and evaluation systems that 
enhance the timeliness, breadth, and relevance 
of epidemiological and behavioral HIV 
surveillance. 
•  stRengthen hiv pRevention alongside 
roLLoUt of mediCaL maLe CirCUmCiSion: 
For countries that promote medical male 
circumcision as a component of comprehensive 
HIV prevention, community education and 
behavioral HIV prevention efforts should be 
strengthened to reinforce the need for continued 
precautions following circumcision procedures. 
reCommendationS for 
PoLiCy maKerS for 
internationaL donorS
•  fund CompRehensive hiv pRevention, 
inCLUding Behavior Change ProgramS: 
Donors should bring as comparable a zeal to 
HIV prevention funding as currently exists for 
treatment assistance. Donors should commit to 
provide full funding for essential behavior change 
and other HIV prevention programs by 2010.12 
For HIV prevention programs in general, donors 
should commit to covering two-thirds of funding 
requirements for 2010, or u.S. $11.9 billion.
•  ReseaRCh: bilateral donors should prioritize 
increased support for research to strengthen 
the evidence base for effective action. Donor-
supported research should place substantially 
greater emphasis on operational and social  
science research. HIV prevention research forums 
 
 
 
 
 
 
 
 
 
 
 
 
 
should expand well beyond behavioral scientists 
to include the broad array of social scientists who 
could contribute to HIV prevention efforts.
•  expand donoR pRioRities: Donors should 
significantly increase funding for sexual- and 
reproductive-health services, capacity building 
for networks of people living with HIV, and 
microfinance programs and other initiatives 
to increase women’s economic independence 
and reduce their vulnerability to HIV. Donor 
assistance should also place greater emphasis 
on building national analytic capacity regarding 
strategic information, program evaluation, and 
epidemiological and behavioral surveillance 
systems. 
•  eliminate donoR RestRiCtions: Donors 
should avoid programmatic restrictions that 
prevent national or local HIV prevention programs 
from using resources to support “best practices” 
in HIV prevention or to respond to documented 
prevention needs.  
reCommendationS for hiv 
ServiCe ProviderS
•  tailoR pRevention pRogRams to loCal 
Context: Development and implementation 
of prevention programs should be informed 
by ethnographic research that assesses key 
behaviors and contextual factors that influence 
individual behavior, characterizes relevant 
social networks, identifies relevant communal 
values, maps local resources, and identifies 
optimal delivery strategies. Prevention program 
implementers should forge a strong, meaningful, 
and ongoing partnership with the community 
served by prevention efforts. 
•  adapt pRevention stRategies: Making 
use of relevant epidemiological, operational, and 
social science research, prevention providers 
should continually reassess the relevance and 
effectiveness of programs. Where indicated, 
prevention programs should be adapted to 
address changes in the social and physical 
environment of the target population.
•  integRate seRviCes: HIV services should be 
closely integrated with key service systems,  
with particular attention to sexual- and 
reproductive-health settings, antenatal settings, 
and tuberculosis clinical settings. Health systems  
and providers should incorporate detection of 
active syphilis and the routine offer of HIV  
testing in antenatal care. 
•  hiv pRevention in tReatment settings: 
all HIV treatment programs should provide 
patients with routine risk-reduction counseling, 
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12  UNAIDS has estimated funding targets for essential HIV interventions to 
achieve universal access to HIV prevention, treatment, care, and support 
(UNAIDS 2007). Funding targets relevant to behavior change for 2010 
include, in U.S. funds, $386 million for communication for social and 
behavioral change, $135 million for community mobilization, $1.35 billion 
for voluntary counseling and testing, $145 million for programs targeting 
young people, $1.54 billion for programs targeting sex workers and their 
clients, $1.18 billion for programs targeting MSM, $3.18 billion for harm-
reduction programs for IDUs, $835 million for workplace prevention 
programs, $261 million for HIV interventions for prisoners, $209 million 
for prevention programs focused on other vulnerable populations, 
$900 million for condom provision (male and female), $2 billion for 
STI management, and $662 million for prevention of mother-to-child 
transmission. 
access to condoms and other prevention tools, 
and other HIV prevention services in their 
clinical settings. treatment programs should 
build partnerships with community-based HIV 
prevention providers to support clinic-based 
prevention efforts and facilitate patient referral 
to community-based prevention resources.  
reCommendationS for hiv 
Prevention reSearCherS
•  soCial sCienCe foCus: Social scientists 
should be actively engaged in research efforts 
to expand the evidence base for HIV prevention. 
Public-sector research agencies, academic 
researchers, and leading foundations should 
prioritize relevant social research in countries 
to improve understanding of factors that 
increase vulnerability, identify and characterize 
programs and specific policy actions to address 
such factors, and inform the development 
and adaptation of national HIV prevention 
strategies. Working partnerships should be 
formed between ethnographers and prevention-
program implementers to increase the capacity 
of providers to undertake the formative research 
required to tailor prevention strategies. 
•  effeCtiveness: Substantially greater 
research focus is needed on studies to assess 
the effectiveness of HIV prevention in real-world 
settings. Studies of combinations of multiple 
prevention components should also be prioritized. 
While not appropriate for all intervention 
trials, biological end points (such as HIV or StI 
incidence) should be used in prevention trials. 
•  Risk Compensation: Substantially greater 
research attention should focus on monitoring 
behavior changes in response to the introduction 
of treatments, medical male circumcision, and 
other developments; identifying contextual 
issues that may influence risk compensation; 
and evaluating interventions to minimize risk 
compensation.
•  new inteRvention appRoaChes: Social 
researchers and behavioral scientists should 
collaborate in the development and testing of new 
prevention interventions that aim to influence 
the norms and behaviors of social networks and 
communities. Greater attention should be paid to 
the evaluation of structural interventions.
•  impRove epidemiologiCal tools: Research 
is urgently needed to develop accessible, 
affordable technologies to permit rapid 
assessment of HIV seroincidence in resource-
limited settings.
reCommendationS 
for PoLiCy maKerS at 
teChniCaL agenCieS
•  suppoRt hiv pRevention planning: a 
coordinated system of technical support is needed 
to assist countries in developing comprehensive 
national HIV plans that include well-targeted, 
evidence-based, and scaled-up prevention 
programming. through coordinated technical 
mechanisms, such as the unaIDS aIDS Strategy 
and action Plan service (housed at the World 
bank), regional aIDS technical support facilities, 
and the technical expertise of u.n. agencies, 
technical experts should provide independent 
feedback on national HIV prevention plans, as 
well as technical support for the development 
and review of these plans. this effort should 
assess three factors: the degree to which national 
programmatic actions are evidence based, the 
alignment of prevention allocations with available 
epidemiological data and documented national 
needs, and whether needed programmatic actions 
are supported by social or structural policy 
actions that address nationally relevant factors 
that increase vulnerability.
•  impRove national infoRmation systems: 
WHo, unaIDS, CDC, and other technical agencies 
should continue to enhance technical support 
to countries in building and strengthening 
national HIV-related data systems. Particular 
emphasis should be placed on improvements to 
behavioral surveillance and to the development 
and implementation of strategies to assess HIV 
seroincidence. 
•  teChniCal ResouRCes on soCial 
reSearCh: unaIDS and WHo, in collaboration 
with social researchers, should develop global 
and regional clearinghouses for HIV-relevant 
social science research and increase assistance 
to countries in the interpretation of social science 
findings and use of research results in the design, 
adaptation, implementation, and evaluation of 
strategies to change HIV risk behaviors.
reCommendationS for 
memBerS of CiviL SoCiety
•  advoCate foR hiv pRevention: at national 
and global levels, HIV advocates should 
actively support a comprehensive response 
to the epidemic that simultaneously brings 
HIV prevention and treatment to scale. It is 
particularly important that HIV treatment activists 
advocate for the simultaneous scaling-up of HIV 
prevention strategies.
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•  monitoR national pRogRess on hiv 
Prevention: With support from donors 
and multilateral agencies, as well as national 
authorities, civil society networks should assist 
in monitoring national HIV prevention efforts and 
work to hold governments, donors, and other 
actors accountable for agreed targets. 
•  paRtiCipate in national pRevention 
PLanning and monitoring: Civil society 
should be integrally involved in national bodies 
that develop and/or monitor national efforts 
to bring HIV prevention to scale, including 
national aIDS Councils and Country Coordinating 
Mechanisms for the Global Fund. Countries 
should define civil society broadly to encompass 
community-based organizations, faith-based 
groups, business and labor, and people living  
with HIV.
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